New Scope-Based ultrasound could spare patients liver biopsies

NCT ID NCT06592820

Recruiting now Diagnosis Sponsor: Olympus Corporation of the Americas Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing a new way to measure liver scarring using an endoscopic ultrasound with special software. About 300 adults with suspected liver disease will undergo this new scan, a standard liver biopsy, and another non-invasive test. The goal is to see if the new technique can accurately diagnose different stages of liver scarring, potentially offering a less invasive alternative to biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) device
What this could lead to: If successful, this could provide a more accurate, less invasive way to diagnose liver scarring, potentially reducing the need for liver biopsies.
What could go wrong: This is an early-stage study comparing a new technique to existing methods. It may not prove superior or may have limitations in certain patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver fibrotic liver disease liver disorder metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LIVER DISEASE FIBROSIS, LIVER MASH MASLD

Contacts and locations

Locations

Brigham and Women's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Geisinger Medical Center
RECRUITING

Danville, Pennsylvania, 17822, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.